REQUEST A DEMO
Total
USD $0.00
Search more companies

Nexus Drugs Private Limited (India)

Main Activities: Soap, Cleaning Compound, and Toilet Preparation Manufacturing
Full name: Nexus Drugs Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Nexus Drugs Private Limited is an unlisted company, incorporated on 02/02/2001. It has its registered office in the State of Telangana, India. Company's corporate identification number (CIN) is U24243TG2001PTC036160 and registration number is 036160. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
Plot No 34, Flat No 201, Magistic Chambers East Srinivas Nagar, S R Nagar
Hyderabad; Telangana; Postal Code: 500038

Contact Details: Purchase the Nexus Drugs Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Nexus Drugs Private Limited report to view the information.
Outstanding Shares:
Purchase the Nexus Drugs Private Limited report to view the information.
Registered Capital:
Purchase the Nexus Drugs Private Limited report to view the information.
Incorporation Date:
February 02, 2001
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Company Performance
Financial values in the chart are available after Nexus Drugs Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-41.61%
Total operating revenue
-41.6%
Operating profit (EBIT)
19.82%
EBITDA
-30.03%
Net Profit (Loss) for the Period
23.09%
Total assets
-11.68%
Total equity
0.61%
Operating Profit Margin (ROS)
0.19%
Net Profit Margin
0.15%
Return on Equity (ROE)
0.12%
Debt to Equity Ratio
-1.17%
Quick Ratio
0.2%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?